🇺🇸 FDA
Patent

US 8865741

Aminoindane compounds and use thereof in treating pain

granted A61KA61K31/167A61K31/40

Quick answer

US patent 8865741 (Aminoindane compounds and use thereof in treating pain) held by Asana BioSciences, LLC expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Asana BioSciences, LLC
Grant date
Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
55
CPC classes
A61K, A61K31/167, A61K31/40, A61K31/438, A61K31/452